Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease)

J C Emond1, P F Whitington

  • 1Liver Transplant Program, University of California, San Francisco 94143-0780, USA.

Insights

Partial biliary diversion (PBD) offers a promising primary therapy for progressive familial intrahepatic cholestasis (PFIC), effectively managing symptoms and halting liver fibrosis. Orthotopic liver transplantation (OLT) remains crucial for advanced cases.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Surgical Gastroenterology

Background:

  • Progressive familial intrahepatic cholestasis (PFIC) is a severe childhood liver disease characterized by cholestasis, fibrosis, and potential cirrhosis.
  • Medical therapies for PFIC are often unsuccessful, leading to poor growth and liver failure.
  • Biliary diversion has shown potential in halting or reversing liver fibrosis progression.

Purpose of the Study:

  • To evaluate the efficacy of partial biliary diversion (PBD) as a primary treatment for PFIC.
  • To reserve orthotopic liver transplantation (OLT) for PFIC patients with progressive disease or established cirrhosis.
  • To assess long-term outcomes of PBD and OLT in pediatric PFIC patients.

Main Methods:

  • Eight PFIC patients underwent partial biliary diversion (PBD) involving a jejunal segment anastomosed to the gallbladder.
  • Eleven PFIC patients with hepatic insufficiency or cirrhosis received standard orthotopic liver transplantation (OLT).
  • Patient outcomes were monitored for clinical symptoms, liver function tests, and hepatic fibrosis progression.

Main Results:

  • Six of eight (75%) patients treated with PBD showed complete symptom resolution and halted fibrosis progression, with normal liver function markers.
  • Two patients did not benefit from PBD due to advanced fibrosis or cirrhosis.
  • Eight of eleven (73%) patients who underwent OLT for advanced disease or cirrhosis are alive postoperatively.

Conclusions:

  • Partial biliary diversion (PBD) is an effective primary therapy for PFIC, capable of resolving symptoms and reversing liver fibrosis.
  • Early diagnosis and intervention are critical for successful PBD outcomes before irreversible liver damage occurs.
  • Orthotopic liver transplantation (OLT) remains a vital option for PFIC patients with advanced liver disease or cirrhosis.